Li Auto (LI) Q1 2025 Earnings Call May 29, 2025 08:00 AM ET Company Participants Janet Zhang - Director of Investor RelationsTie Li - CFO & Executive DirectorYan Xie - Chief Technology OfficerBin Wang - VP - Investment BankingPaul Gong - Executive Director Conference Call Participants Tim Hsiao - AnalystYingbo Xu - AnalystTina Hou - AnalystJing Chang - Analyst Operator Ladies and gentlemen, thank you for standing by for Lee Auto's First Quarter twenty twenty five Earnings Conference Call. At this time, all ...

Financial Data and Key Metrics Changes - The competitive intensity in the market has increased, with gross adds showing double-digit growth on the postpaid phone side [6][10] - The company has seen a slight increase in churn due to price hikes and competitive pressures, but expects to return to a business-as-usual (BAU) posture in the second half of the year [54][74] Business Line Data and Key Metrics Changes - The broadband and mobility businesses are identified as the two engines of growth, with a clear path to becoming the number one converged player in America [10][14] - The company aims to cover 40 million homes with fiber and continues to see strong momentum in its Fixed Wireless Access (FWA) product, targeting 8 to 9 million subscribers [13][24] Market Data and Key Metrics Changes - The switcher pool has increased, with both port-ins and port-outs rising, indicating a competitive environment [6][10] - The company has a strong position in the prepaid market, having gained market share over the last three quarters [37][38] Company Strategy and Development Direction - The company aims to be the number one converged player in America, focusing on both mobility and broadband [10][14] - The strategy includes leveraging AI for operational efficiencies and enhancing customer care, which is seen as a potential differentiator in the market [106][109] Management's Comments on Operating Environment and Future Outlook - Management acknowledges the competitive landscape but believes the company's value proposition resonates well with customers [7][10] - The company expects to see continued growth in gross adds and a reduction in churn as it implements its strategies [54][74] Other Important Information - The company has committed to a million-plus new fiber offerings post-acquisition of Frontier, with a focus on reducing build costs through automation and AI [21][23] - Adjacent products and perks are becoming a significant part of the business, with a projected $2 billion run rate and mid-30% margins [78][81] Q&A Session Summary Question: What are the expectations for gross adds in the second half of the year? - Management expects gross add momentum to continue due to a strong value proposition and improved sales execution [56][61] Question: How does the company view the competitive landscape and its impact on ARPU? - The company does not aggressively pursue pre-to-post migration but focuses on serving customers well in the prepaid space, maintaining a premium mix [63][64] Question: What is the strategy for reducing churn? - A strong value proposition, cross-selling opportunities, and loyalty programs are key strategies for reducing churn [69][72] Question: How does the company leverage AI in its operations? - AI is used to enhance customer care, improve operational efficiencies, and provide personalized experiences [106][109]

Best Buy (BBY) Q1 2026 Earnings Call May 29, 2025 08:00 AM ET Company Participants Mollie O'Brien - Vice President, Investor RelationsCorie Barry - CEOMatt Bilunas - CFO & Senior EVP of Enterprise StrategyJason Bonfig - Senior Executive VP of Customer Offerings & FulfillmentSteven Zaccone - Director, Equity Research, Hardlines RetailJonathan Matuszewski - Senior Vice President Conference Call Participants Scot Ciccarelli - MD & Senior Research AnalystMichael Baker - Managing Director, Senior Research Analys ...

Financial Data and Key Metrics Changes - The company reported just under $5 billion in cash on the balance sheet as of March 31, 2025, with no debt [11][35] - The net cash usage for the quarter was approximately $150 million, which is considered a normal quarter for the business [35] - The company has repurchased $1.3 billion of its own stock, reducing the share count by nearly 15% [11][35] Business Line Data and Key Metrics Changes - The company is focused on multiple late-stage pipeline products, including brevacitinib and IMG1402, with significant clinical execution and progress across all main clinical franchises [7][8] - Brevacitinib is expected to be a market therapy within the next couple of years, with pivotal studies ongoing in multiple indications [8][12] - The company has initiated studies in dermatomyositis and cutaneous sarcoidosis, with data readouts expected in the near future [14][18] Market Data and Key Metrics Changes - The company is addressing a patient population with high unmet needs, particularly in dermatomyositis, where the only approved therapy is IVIG [40] - The estimated market for dermatomyositis is between 40,000 to 70,000 patients in the U.S., with approximately 34,000 currently treated [100] Company Strategy and Development Direction - The company aims to capitalize on its strong cash position to drive profitability and pipeline expansion, with $2 billion reserved for future opportunities [11][12] - The focus is on indications with high unmet needs and potential for first-in-class therapies, particularly in the FcRn space [19][88] - The company is preparing for a busy data generation period over the next 36 months, with multiple potential blockbuster launches anticipated [10][31] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the upcoming data readouts and the potential for significant market opportunities, particularly in immunology [10][31] - The company acknowledges the challenging market environment but feels well-positioned compared to peers [12][35] - Management emphasized the importance of capital allocation and the strategic focus on high unmet medical needs [11][12] Other Important Information - The company is in the summary judgment phase of its LNP litigation against Moderna and Pfizer, with a trial expected to follow [32][34] - The company is also awaiting a ruling in the Pfizer case, which is anticipated later this year [51] Q&A Session Summary Question: What are the expectations for the DM study? - Management indicated that a positive study with statistically significant separation from placebo is necessary for success in the DM study [39][40] Question: Can you provide an update on the LNP litigation against Moderna? - Management noted that narrowing the case is a normal part of patent litigation and that parameters will be evident in the near future [43][44] Question: What is the status of the pending Pfizer Markman decision? - Management stated that the timing of the Markman decision is at the judge's discretion and is hopeful for a ruling later this year [51] Question: How is the company planning to position Brevacitinib if approved? - Management views the entire market as addressable and believes many patients represent low-hanging fruit due to the lack of options [60] Question: What are the expectations for the placebo response in the DM study? - Management referenced published data from similar studies that showed a well-behaved placebo response, which is encouraging [70] Question: What is the observable population for dermatomyositis in the U.S.? - Management estimates the DM market to be between 40,000 to 70,000 patients, with around 34,000 currently treated [100]

Best Buy (BBY) Q1 2026 Earnings Call May 29, 2025 08:00 AM ET Speaker0 Ladies and gentlemen, thank you for standing by. Welcome to Best Buy's First Quarter Fiscal twenty twenty six Earnings Conference Call. At this time, all participants are in a listen only mode. Later, we will conduct a question and answer session. At that time, if you have a question, you will need to press star one on your phone. If you choose to be taken out of the question queue, please press star one again. As a reminder, this call i ...

Financial Data and Key Metrics Changes - The company has transformed its operations over the past five years, achieving an annual growth in cash flow and earnings of 8% to 10% at constant prices and margins [8][10] - The company plans to grow earnings by $20 billion and cash flow by $30 billion by the end of the decade [17] - The enterprise value of the company is approximately $500 billion, with a total shareholder return of 11% last year [16][20] Business Line Data and Key Metrics Changes - The company is organized into three segments: upstream (oil and gas), product solutions (upgrading oil and gas to higher value products), and low carbon solutions [11][12] - The upstream segment is expected to triple the capacity of its Guyana operations and increase Permian assets by 50% over the next five years [9][56] - The company has doubled its earnings per barrel in upstream production over the last five years [57] Market Data and Key Metrics Changes - The demand for crude oil is at an all-time high, with expectations for continued growth despite economic concerns [42][44] - Natural gas prices in Europe have stabilized at around $12 to $13 per million BTU, following a spike due to supply disruptions [48] Company Strategy and Development Direction - The company aims to maintain an 8% to 10% growth rate in earnings and cash flow through the end of the decade, focusing on high-return investment opportunities [10][17] - The strategy includes a strong emphasis on carbon capture and sequestration, positioning the company as a leader in low carbon solutions [13][78] - The company is not participating in renewable energy but is focused on technologies that align with its core capabilities [13] Management's Comments on Operating Environment and Future Outlook - Management believes that achieving net zero emissions by 2050 is unrealistic and emphasizes the need for reliable and affordable energy [24][29] - The company anticipates that oil and gas will still represent 50% of the energy mix by 2050, despite efforts to reduce emissions [29] - The current regulatory environment is seen as inefficient, particularly regarding infrastructure permitting, which hampers operational efficiency [50][52] Other Important Information - The company has a consistent and growing dividend, having increased it for 42 consecutive years, and plans to repurchase $20 billion of stock this year [18][19] - The company has a strong balance sheet with a net debt to capital ratio of 7% and a double A credit rating [92] Q&A Session Summary Question: What is the nature of your energy outlook? - Management distinguishes between normative and predictive outlooks, asserting that their energy outlook is realistic and affordable, predicting a 15% increase in energy demand by 2050 [22][24] Question: How do you view the current oil price cycle? - Management describes the current oil price cycle as normal, with prices influenced by sentiment and supply-demand dynamics, noting that prices have softened recently [41][46] Question: What are your thoughts on the regulatory environment? - Management criticizes the lengthy permitting process for infrastructure projects in the U.S., calling for a more efficient system to facilitate energy production [50][52] Question: Can you provide an update on the arbitration proceedings with Hess? - Management confirms that arbitration is ongoing and expects a decision within two to three months, emphasizing that operational relationships remain strong regardless of the outcome [62][65] Question: How does the company plan to manage future cash flows? - Management expresses confidence in generating significant free cash flow by 2030, with a focus on maintaining a strong balance sheet and returning value to shareholders [97][98]

Li Auto (LI) Q1 2025 Earnings Call May 29, 2025 08:00 AM ET Speaker0 Ladies and gentlemen, thank you for standing by for Lee Auto's First Quarter twenty twenty five Earnings Conference Call. At this time, all participants are in listen only mode. Today's conference call is being recorded. I will now turn the call over to your host, Ms. Janet Zhang, Investor Relations Director of Li Auto. Please go ahead, Janet. Speaker1 Thank you, Kelly. Good evening, and good morning, everyone. Welcome to Li Auto's first q ...

Roivant Sciences (ROIV) Q4 2025 Earnings Call May 29, 2025 08:00 AM ET Speaker0 Good day, and welcome to the Worrevant Fourth Quarter twenty twenty four Earnings Call. At this time, all participants are in a listen only mode. After the speakers' presentation, there will be a question and answer session. Instructions will be given at that time. As a reminder, this call may be recorded. I would now like to turn the call over to Stephanie Lee. Please go ahead. Speaker1 Good morning, and thanks for joining toda ...

FactSet (FDS) FY 2025 Conference May 29, 2025 08:00 AM ET Speaker0 Hi. Good morning, everyone. Thanks for joining us today. My name is Kelsey Chew. I'm the financial information services analyst at Autonomous. And with me on stage today, we have mister Phil Snow, who is the CEO of FactSet. Thanks for joining us today, Phil. Speaker1 Thanks for having us. Yeah. Speaker0 So, Phil, I believe you started your career at FactSet in 1996 as a consultant and was officially named CEO in 2015. So just wondering if yo ...

TripAdvisor (TRIP) FY 2025 Conference May 29, 2025 08:00 AM ET Speaker0 Alright. Thanks for joining us for the ATM slot on day two of the forty first Bernstein Strategic Decisions Conference. If anyone doesn't know me, I'm Richard Clark. I'm the analyst who covers global hotels and and leisure or leisure at Bernstein. And delighted to have Matt Goldberg with me today, the, the president and CEO, of TripAdvisor. Welcome. Speaker1 Thanks for joining us today. Thank you, Richard. Speaker0 So, I mean, look, let ...